Cargando…
Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies
Hepatocellular carcinoma (HCC) is one of the most common digestive malignancies. HCC It ranges as the fifth most common cause of cancer mortality worldwide. While The prognosis of metastatic or advanced HCC is still quite poor. Recently, locoregional treatment, especially local ablation therapies, p...
Autores principales: | Xiao, Chunying, Liu, Sheng, Ge, Ge, Jiang, Hao, Wang, Liezhi, Chen, Qi, Jin, Chong, Mo, Jinggang, Li, Jin, Wang, Kunpeng, Zhang, Qianqian, Zhou, Jianyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939531/ https://www.ncbi.nlm.nih.gov/pubmed/36814489 http://dx.doi.org/10.3389/fphar.2023.1086813 |
Ejemplares similares
-
The mechanism of flavonoids from Cyclocarya paliurus on inhibiting liver cancer based on in vitro experiments and network pharmacology
por: Mo, Jinggang, et al.
Publicado: (2023) -
The multikinase inhibitor axitinib in the treatment of advanced hepatocellular carcinoma: the current clinical applications and the molecular mechanisms
por: Jiang, Hao, et al.
Publicado: (2023) -
Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?
por: Zhao, Shankun, et al.
Publicado: (2021) -
Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go
por: Wang, Kunpeng, et al.
Publicado: (2021) -
PIK3R3 is upregulated in liver cancer and activates Akt signaling to control cancer growth by regulation of CDKN1C and SMC1A
por: Lin, Weidong, et al.
Publicado: (2023)